drugset / Trial / NCT07020559

Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial

NCT07020559 ↗

Phase 4 Not yet recruiting 56 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Diabetic wounds are difficult to heal. Autologous platelets in diabetic patients with renal insufficiency have poor function. Allogeneic platelet plasma has a promising application prospect. Comparing the efficacy and safety differences between allogeneic platelet plasma and autologous platelet plasma is of significant importance and value for the clinical application.

Timeline

Start
2026-04
Primary completion
2027-12
Completion
2028-05

Drugs

EvaluationDrugModalityDoseRoute
Subject allogeneic platelet plasma Unknown — —
Comparator autologous platelet plasma Unknown — —